Syllable Stock
HealthTechLooking to sell Syllable stock or options?
Syllable has developed a text and voice-based platform designed to enhance communication between patients and healthcare providers. This platform allows for seamless exchanges regarding primary care, specialist referrals, vaccinations, and general practice details, empowering patients to access healthcare information and guidance without needing to be in a clinical environment.
Investors Include:
Oak HC/FT, Esther Dyson, Greylock, Northwell Holdings, Khosla Ventures, New Enterprise Associates, Verily Life Sciences, TT Capital Partners, MemorialCare Innovation Fund, TCV, S32.